David James Vaughan, Chief Development Officer at Antibe Therapeutics, holds 52.50K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, David James Vaughan Bought $52,500 shares of Antibe Therapeutics on Sep 26, 2020 for an estimated value of 17.85K.